Ann M. Bode
- Biochemistry top 0.1%
- Phytochemicals and Antioxidant Activities 24
- Cancer Research top 0.2%
- Cancer, Hypoxia, and Metabolism 23
- Molecular Biology top 0.2%
- Melanoma and MAPK Pathways 43
- PI3K/AKT/mTOR signaling in cancer 29
- Genomics, phytochemicals, and oxidative stress 26
- Ubiquitin and proteasome pathways 23
- Toxicology top 0.1%
-
- Cancer-related Molecular Pathways 59
-
- Skin Protection and Aging 26
- Journals
- Cancer Research (61 papers)Journal of Biological Chemistry (39 papers)Cancer Prevention Research (33 papers)
- Partner nations
- United StatesChinaSouth Korea
In The Last Decade
Ann M. Bode
417 papers receiving 20.7k citations
Hit Papers
Peers
Comparison fields: 5 of 173
- Biochemistry 1.7k
- Cancer Research 3.3k
- Applied Microbiology and Biotechnology 378
- Molecular Biology 12.4k
- Toxicology 543
Countries citing papers authored by Ann M. Bode
This map shows the geographic impact of Ann M. Bode's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann M. Bode with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann M. Bode more than expected).
Fields of papers citing papers by Ann M. Bode
This network shows the impact of papers produced by Ann M. Bode. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann M. Bode. The network helps show where Ann M. Bode may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ann M. Bode, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 10 | |
| 2 | 2024 | 6 | |
| 3 | 2020 | 5 | |
| 4 | 2018 | 11 | |
| 5 | 2018 | 15 | |
| 6 | 2018 | 36 | |
| 7 | 2015 | 30 | |
| 8 | 2014 | 91 | |
| 9 | 2014 | 47 | |
| 10 | 2013 | 36 | |
| 11 | 2013 | 20 | |
| 12 | 2013 | 51 | |
| 13 | 2013 | 53 | |
| 14 | 2011 | 33 | |
| 15 | 2010 | 79 | |
| 16 | 2010 | 89 | |
| 17 | 2009 | 149 | |
| 18 | 2009 | 58 | |
| 19 | 2009 | 74 | |
| 20 | 2007 | 15 |
About Ann M. Bode
Ann M. Bode is a scholar working on Applied Microbiology and Biotechnology, Oncology and Cancer Research, having authored 422 papers that have together received 21.1k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (59 papers), Melanoma and MAPK Pathways (43 papers), PI3K/AKT/mTOR signaling in cancer (29 papers), Genomics, phytochemicals, and oxidative stress (26 papers), Skin Protection and Aging (26 papers), Phytochemicals and Antioxidant Activities (24 papers), Ubiquitin and proteasome pathways (23 papers) and Cancer, Hypoxia, and Metabolism (23 papers). The work is most often cited by research in Biochemistry (1.7k citations), Cancer Research (3.3k citations) and Applied Microbiology and Biotechnology (378 citations). Ann M. Bode has collaborated with scholars based in United States, China and South Korea. Frequent co-authors include Zigang Dong, Richard C. Rose, Weiya Ma, Ki Won Lee, Yong‐Yeon Cho, Feng Zhu, Mee‐Hyun Lee, Ya Cao, Xiangjian Luo and Mengqiu Song. Their work appears in journals such as Cancer Research, Journal of Biological Chemistry, Cancer Prevention Research, Carcinogenesis and Molecular Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.